CARA THERAPEUTICS INC (CARA) Institutional Ownership
None of the superinvestors we track currently report CARA THERAPEUTICS INC (CARA) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in CARA THERAPEUTICS INC (CARA), this page will show smart money ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2024 | 2 | $684,368 | 2,221,974 |
| Q2 2024 | 2 | $774,379 | 3,001,468 |
| Q1 2024 | 2 | $1,652,916 | 3,147,536 |
| Q4 2023 | 2 | $1,346,908 | 2,509,130 |
| Q3 2023 | 2 | $2,978,151 | 2,084,297 |
| Q2 2023 | 2 | $4,993,917 | 2,198,251 |
| Q1 2023 | 2 | $8,506,136 | 1,767,943 |
| Q4 2022 | 1 | $18,499,016 | 1,722,441 |
| Q3 2022 | 1 | $15,914 | 1,700,230 |
| Q2 2022 | 1 | $15,510 | 1,698,822 |
| Q1 2022 | 2 | $22,520 | 1,853,500 |
| Q4 2021 | 2 | $24,577 | 2,017,811 |
Related CARA Institutional Insights:
- CARA Institutional Ownership & Insiders Activity
- CARA Institutional Ownership & 13F Activity
- CARA Top Institutional Shareholders
- CARA Institutional Buying Activity
- CARA Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- CARA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings